Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 2,817 shares, an increase of 63.4% from the October 15th total of 1,724 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 95,128 shares, the short-interest ratio is currently 0.0 days.
Guided Therapeutics Stock Performance
GTHP stock traded down $0.01 during trading on Monday, hitting $0.11. 3,200 shares of the company traded hands, compared to its average volume of 27,274. The firm has a market capitalization of $10.80 million, a PE ratio of -2.75 and a beta of 0.78. Guided Therapeutics has a 1 year low of $0.10 and a 1 year high of $0.54. The company has a 50-day moving average of $0.19 and a 200-day moving average of $0.25.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last announced its quarterly earnings results on Monday, November 16th. The company reported ($0.01) EPS for the quarter.
About Guided Therapeutics
Guided Therapeutics is a medical technology company focused on developing tools for the detection of cervical disease. Its principal product is the LuViva Advanced Cervical Scan, a non-invasive device designed to assess cervical tissue for signs associated with precancerous changes and cancer. LuViva uses optical technologies to examine tissue and provide information that can support cervical disease evaluation. The company’s work centers on offering an alternative to diagnostic approaches that rely on collecting and analyzing tissue samples.
Recommended Stories
- Five stocks we like better than Guided Therapeutics
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
